These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 30587626)

  • 1. Prognostic Value of Red Blood Cell Distribution Width in Non-small Cell Lung Cancer Treated With Anti-programmed Cell Death-1 Antibody.
    Kiriu T; Yamamoto M; Nagano T; Koyama K; Katsurada M; Tamura D; Nakata K; Tachihara M; Kobayashi K; Nishimura Y
    In Vivo; 2019; 33(1):213-220. PubMed ID: 30587626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of red blood cell distribution width, neutrophil-to-lymphocyte ratio, and hemoglobin-to-red blood cell distribution width ratio in the progression of non-small cell lung cancer.
    Chen JL; Wu JN; Lv XD; Yang QC; Chen JR; Zhang DM
    PLoS One; 2020; 15(8):e0237947. PubMed ID: 32833961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody.
    Suh KJ; Kim SH; Kim YJ; Kim M; Keam B; Kim TM; Kim DW; Heo DS; Lee JS
    Cancer Immunol Immunother; 2018 Mar; 67(3):459-470. PubMed ID: 29204702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy.
    Scilla KA; Bentzen SM; Lam VK; Mohindra P; Nichols EM; Vyfhuis MA; Bhooshan N; Feigenberg SJ; Edelman MJ; Feliciano JL
    Oncologist; 2017 Jun; 22(6):737-742. PubMed ID: 28533476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer.
    Bagley SJ; Kothari S; Aggarwal C; Bauml JM; Alley EW; Evans TL; Kosteva JA; Ciunci CA; Gabriel PE; Thompson JC; Stonehouse-Lee S; Sherry VE; Gilbert E; Eaby-Sandy B; Mutale F; DiLullo G; Cohen RB; Vachani A; Langer CJ
    Lung Cancer; 2017 Apr; 106():1-7. PubMed ID: 28285682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of red cell distribution width as a diagnostic and prognostic marker in non-small cell lung cancer.
    Song B; Shi P; Xiao J; Song Y; Zeng M; Cao Y; Zhu X
    Sci Rep; 2020 Sep; 10(1):15717. PubMed ID: 32973271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of the Red Blood Cell Distribution Width in Resected Pathologic Stage I Nonsmall Cell Lung Cancer.
    Toyokawa G; Shoji F; Yamazaki K; Shimokawa M; Takeo S
    Semin Thorac Cardiovasc Surg; 2020 Winter; 32(4):1036-1045. PubMed ID: 31009697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ratio of hemoglobin to red cell distribution width as a novel prognostic parameter in esophageal squamous cell carcinoma: a retrospective study from southern China.
    Sun P; Zhang F; Chen C; Bi X; Yang H; An X; Wang F; Jiang W
    Oncotarget; 2016 Jul; 7(27):42650-42660. PubMed ID: 27223088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated red cell distribution width contributes to a poor prognosis in patients with esophageal carcinoma.
    Wan GX; Chen P; Cai XJ; Li LJ; Yu XJ; Pan DF; Wang XH; Wang XB; Cao FJ
    Clin Chim Acta; 2016 Jan; 452():199-203. PubMed ID: 26633854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and survival values of neutrophil-lymphocyte ratio (NLR) and red blood cell distribution width (RDW) in esophageal cancer.
    Han F; Liu Y; Cheng S; Sun Z; Sheng C; Sun X; Shang X; Tian W; Wang X; Li J; Liu D; Wang Y; Zhang B; Ju Y
    Clin Chim Acta; 2019 Jan; 488():150-158. PubMed ID: 30389457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of Red Cell Distribution Width in Advanced Non-Small Cell Lung Cancer Patients.
    Zhan Z; Fei Z; Xu B; Zhong D; Dong D
    Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative red cell distribution width in patients undergoing pulmonary resections for non-small-cell lung cancer.
    Warwick R; Mediratta N; Shackcloth M; Shaw M; McShane J; Poullis M
    Eur J Cardiothorac Surg; 2014 Jan; 45(1):108-13. PubMed ID: 23711463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of PD-1 on CD4+ T cells in peripheral blood associates with poor clinical outcome in non-small cell lung cancer.
    Zheng H; Liu X; Zhang J; Rice SJ; Wagman M; Kong Y; Zhu L; Zhu J; Joshi M; Belani CP
    Oncotarget; 2016 Aug; 7(35):56233-56240. PubMed ID: 27191652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing PDL-1 and PD-1 in Non-Small Cell Lung Cancer: A Novel Immunoscore Approach.
    Paulsen EE; Kilvaer TK; Khanehkenari MR; Al-Saad S; Hald SM; Andersen S; Richardsen E; Ness N; Busund LT; Bremnes RM; Donnem T
    Clin Lung Cancer; 2017 Mar; 18(2):220-233.e8. PubMed ID: 27816392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comprehensive Analysis of Programmed Cell Death Ligand-1 Expression With the Clone SP142 Antibody in Non-Small-Cell Lung Cancer Patients.
    Takada K; Toyokawa G; Okamoto T; Shimokawa M; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takamori S; Katsura M; Shoji F; Oda Y; Maehara Y
    Clin Lung Cancer; 2017 Sep; 18(5):572-582.e1. PubMed ID: 28318951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of red cell distribution width in the prognosis of patients with gastric cancer.
    Yazici P; Demir U; Bozkurt E; Isil GR; Mihmanli M
    Cancer Biomark; 2017; 18(1):19-25. PubMed ID: 27814271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pre-treatment neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and red cell distribution width predict prognosis in patients with laryngeal carcinoma.
    Kara M; Uysal S; Altinişik U; Cevizci S; Güçlü O; Dereköy FS
    Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):535-542. PubMed ID: 27520567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of pre-treatment red blood cell distribution width in lung cancer: a meta-analysis.
    Wang Y; Zhou Y; Zhou K; Li J; Che G
    Biomarkers; 2020 May; 25(3):241-247. PubMed ID: 32064949
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the prognostic utility of the hemoglobin-to-red cell distribution width ratio in head and neck cancer.
    Tham T; Olson C; Wotman M; Teegala S; Khaymovich J; Coury J; Costantino P
    Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2869-2878. PubMed ID: 30251123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.